Plant-Made Pharmaceuticals And The Democratization Of Health Care Seeking Alpha The Ibiolaunch has successfully expressed both humanized and chimeric monoclonal antibodies, Paviluzumab and Rituximab, respectfully. Astrazeneca (AZN), parent of MedImmune, currently markets Paviluzumab for Respiratory syncytial virus and Genentech, ... |
